Trial intelligence / Profile preview

Remimazolam vs propofol for postoperative sleep and recovery in elderly obese TKA patients

ChiCTR2500109438Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of USTC
Start
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in sleep disorder (2 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Quality of sleep. Planned start Sep 2025; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

sleep disorder

Beyond the preview

Go deeper on ChiCTR2500109438.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500109438.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call